Novo Nordisk stock surges 7% after Ozempic maker’s latest weight loss drug shows promise
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. Read More]
The new treatment targets gut hormone GLP-1 but also mimics amylin, a hormone released by the pancreas that suppresses hunger. Read More]
Former WBO Junior middleweight champion Tim Tszyu could face Joey Spencer in April in Australia. This would be a confidence booster for the 29-year-old Tszyu (24-2, 17 KOs), who has… Read More »Tszyu Vs. Spencer: Potential April Fight In Australia
Social media is chock full of people breaking up with the king of fitness trackers. Read More]
GRAND RAPIDS, Mich., Jan. 24, 2025 /PRNewswire/ — First Financial (NYSE:) Bank (Nasdaq: FFBC) is expanding into Michigan with the introduction of Grand Rapids native and highly experienced banker Chris… Read More »First Financial Bank Expands to Grand Rapids By Investing.com
Investing.com — Morgan Stanley advised investors to favour defensive, diversified energy stocks as it lowered earnings estimates across the oilfield services and equipment sector amid a subdued macroeconomic outlook for 2025.… Read More »Morgan Stanley sees defensive plays as key in challenging energy market By Investing.com
Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Friedrich Merz, the frontrunner in the race to become German… Read More »Friedrich Merz vows to seal Germany’s borders after Bavaria knife attack
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy… Read More »CEOs: Implementing AI without understanding this one thing could cost you
Accuses founders of using its registered trademark without permission. Read More]
Mark Zuckerberg has announced a new spending plan for Meta which includes building an “AI engineer” to help with coding. Read More]
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin studies this year. Read More]